These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 31837276)

  • 1. Improvement of oral function and hygiene in Parkinson's disease: A randomised controlled clinical trial.
    Baram S; Karlsborg M; Bakke M
    J Oral Rehabil; 2020 Mar; 47(3):370-376. PubMed ID: 31837276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orofacial function and oral health in patients with Parkinson's disease.
    Bakke M; Larsen SL; Lautrup C; Karlsborg M
    Eur J Oral Sci; 2011 Feb; 119(1):27-32. PubMed ID: 21244508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of orofacial physiotherapeutic and hygiene interventions on oral health-related quality of life in patients with Parkinson's disease: A randomised controlled trial.
    Baram S; Karlsborg M; Øzhayat EB; Bakke M
    J Oral Rehabil; 2021 Sep; 48(9):1035-1043. PubMed ID: 34129743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Functional Chewing Training on tongue thrust and drooling in children with cerebral palsy: a randomised controlled trial.
    Inal Ö; Serel Arslan S; Demir N; Tunca Yilmaz Ö; Karaduman AA
    J Oral Rehabil; 2017 Nov; 44(11):843-849. PubMed ID: 28681387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Facts and controversies regarding oral health in Parkinson's disease: A case-control study in Spanish patients.
    García-De-La-Fuente AM; Lafuente-Ibáñez-de-Mendoza I; Lartitegui-Sebastián MJ; Marichalar-Mendia X; Echebarria-Goikouria MÁ; Aguirre-Urizar JM
    Med Oral Patol Oral Cir Bucal; 2022 Sep; 27(5):e419-e425. PubMed ID: 35368008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes of three Parkinson's disease patients treated with mandibular implant overdentures.
    Heckmann SM; Heckmann JG; Weber HP
    Clin Oral Implants Res; 2000 Dec; 11(6):566-71. PubMed ID: 11168250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-assessment of oral health, dental health care and oral health-related quality of life among Parkinson's disease patients.
    Barbe AG; Bock N; Derman SH; Felsch M; Timmermann L; Noack MJ
    Gerodontology; 2017 Mar; 34(1):135-143. PubMed ID: 27231151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral Hygiene in Patients with Parkinson's Disease.
    Batista LM; Portela de Oliveira MT; Magalhaes WB; Bastos PL
    R I Med J (2013); 2015 Nov; 98(11):35-7. PubMed ID: 26517254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Masticatory function and oral sensorimotor ability in Parkinson's disease: Levodopa on versus off periods.
    Rodrigues Ribeiro G; Heitor Campos C; Barbosa Câmara-Souza M; Fraga do Amaral C; Rodrigues Garcia RCM
    Spec Care Dentist; 2019 Mar; 39(2):77-83. PubMed ID: 30597591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Saliva changes in Parkinson's disease patients after injection of Botulinum neurotoxin type A.
    Tiigimäe-Saar J; Tamme T; Rosenthal M; Kadastik-Eerme L; Taba P
    Neurol Sci; 2018 May; 39(5):871-877. PubMed ID: 29460161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of an oral function improvement program based on remote intervention].
    Sekiguchi H; Obuchi S; Kojima N; Arai T; Hirano H; Kojima M
    Nihon Ronen Igakkai Zasshi; 2010; 47(3):226-34. PubMed ID: 20616449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkinson disease: systemic and orofacial manifestations, medical and dental management.
    Friedlander AH; Mahler M; Norman KM; Ettinger RL
    J Am Dent Assoc; 2009 Jun; 140(6):658-69. PubMed ID: 19491161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drooling in Parkinson's disease: A randomized controlled trial of incobotulinum toxin A and meta-analysis of Botulinum toxins.
    Narayanaswami P; Geisbush T; Tarulli A; Raynor E; Gautam S; Tarsy D; Gronseth G
    Parkinsonism Relat Disord; 2016 Sep; 30():73-7. PubMed ID: 27406786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral health and the elderly in Nigeria: a case for oral health promotion.
    Ojofeitimi EO; Adedigba MA; Ogunbodede EO; Fajemilehin BR; Adegbehingbe BO
    Gerodontology; 2007 Dec; 24(4):231-4. PubMed ID: 17999735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dental health of patients with Parkinson's disease in Iceland.
    Einarsdóttir ER; Gunnsteinsdóttir H; Hallsdóttir MH; Sveinsson S; Jónsdóttir SR; Olafsson VG; Bragason TH; Saemundsson SR; Holbrook WP
    Spec Care Dentist; 2009; 29(3):123-7. PubMed ID: 19938251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drooling in Parkinson's Disease: Evidence of a Role for Divided Attention.
    Reynolds H; Miller N; Walker R
    Dysphagia; 2018 Dec; 33(6):809-817. PubMed ID: 29785679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Home-based step training using videogame technology in people with Parkinson's disease: a single-blinded randomised controlled trial.
    Song J; Paul SS; Caetano MJD; Smith S; Dibble LE; Love R; Schoene D; Menant JC; Sherrington C; Lord SR; Canning CG; Allen NE
    Clin Rehabil; 2018 Mar; 32(3):299-311. PubMed ID: 28745063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkinson's disease impairs masticatory function.
    Ribeiro GR; Campos CH; Rodrigues Garcia RCM
    Clin Oral Investig; 2017 May; 21(4):1149-1156. PubMed ID: 27291219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of zinc acetate and magnolia bark extract added to chewing gum on volatile sulfur-containing compounds in the oral cavity.
    Porciani PF; Grandini S
    J Clin Dent; 2012; 23(3):76-9. PubMed ID: 23210417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sialorrhea in patients with Parkinson's disease: safety and administration of botulinum neurotoxin.
    Egevad G; Petkova VY; Vilholm OJ
    J Parkinsons Dis; 2014; 4(3):321-6. PubMed ID: 24919823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.